Cohen Klingenstein’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,285
| Closed | -$609K | – | 245 |
|
|
2021
Q3 | $609K | Sell |
4,285
-5,176
| -55% | -$761K | 0.03% | 204 |
|
|
2021
Q2 | $1.48M | Hold |
9,461
| – | – | 0.06% | 151 |
|
|
2021
Q1 | $1.47M | Hold |
9,461
| – | – | 0.07% | 146 |
|
|
2020
Q4 | $1.42M | Hold |
9,461
| – | – | 0.07% | 147 |
|
|
2020
Q3 | $1.25M | Hold |
9,461
| – | – | 0.07% | 143 |
|
|
2020
Q2 | $1.1M | Hold |
9,461
| – | – | 0.07% | 149 |
|
|
2020
Q1 | $928K | Hold |
9,461
| – | – | 0.07% | 149 |
|
|
2019
Q4 | $1.38M | Hold |
9,461
| – | – | 0.08% | 137 |
|
|
2019
Q3 | $1.26M | Hold |
9,461
| – | – | 0.08% | 138 |
|
|
2019
Q2 | $1.08M | Hold |
9,461
| – | – | 0.08% | 146 |
|
|
2019
Q1 | $1.17M | Hold |
9,461
| – | – | 0.08% | 114 |
|
|
2018
Q4 | $953K | Hold |
9,461
| – | – | 0.14% | 91 |
|
|
2018
Q3 | $1.21M | Hold |
9,461
| – | – | 0.15% | 92 |
|
|
2018
Q2 | $1.02M | Hold |
9,461
| – | – | 0.14% | 97 |
|
|
2018
Q1 | $1M | Hold |
9,461
| – | – | 0.14% | 96 |
|
|
2017
Q4 | $1.11M | Hold |
9,461
| – | – | 0.16% | 94 |
|
|
2017
Q3 | $1.07M | Hold |
9,461
| – | – | 0.16% | 94 |
|
|
2017
Q2 | $1.18M | Hold |
9,461
| – | – | 0.18% | 88 |
|
|
2017
Q1 | $1.12M | Hold |
9,461
| – | – | 0.18% | 89 |
|
|
2016
Q4 | $948K | Hold |
9,461
| – | – | 0.16% | 95 |
|
|
2016
Q3 | $1.19M | Hold |
9,461
| – | – | 0.21% | 77 |
|
|
2016
Q2 | $1.11M | Hold |
9,461
| – | – | 0.2% | 82 |
|
|
2016
Q1 | $979K | Sell |
9,461
-355
| -4% | -$34.3K | 0.18% | 90 |
|
|
2015
Q4 | $978K | Hold |
9,816
| – | – | 0.18% | 90 |
|
|
2015
Q3 | $895K | Hold |
9,816
| – | – | 0.18% | 88 |
|
|
2015
Q2 | $1.04M | Hold |
9,816
| – | – | 0.19% | 88 |
|
|
2015
Q1 | $1.12M | Sell |
9,816
-15
| -0.2% | -$1.71K | 0.2% | 78 |
|
|
2014
Q4 | $1.08M | Sell |
9,831
-783
| -7% | -$82.5K | 0.2% | 82 |
|
|
2014
Q3 | $1.04M | Hold |
10,614
| – | – | 0.18% | 84 |
|
|
2014
Q2 | $1.07M | Hold |
10,614
| – | – | 0.2% | 83 |
|
|
2014
Q1 | $975K | Hold |
10,614
| – | – | 0.19% | 86 |
|
|
2013
Q4 | $960K | Hold |
10,614
| – | – | 0.19% | 87 |
|
|
2013
Q3 | $846K | Hold |
10,614
| – | – | 0.18% | 87 |
|
|
2013
Q2 | $772K | Buy |
+10,614
| New | +$794K | 0.18% | 89 |
|
Other funds holding ZBH
Cohen Klingenstein's ZBH Position: Q4 2021 in Review
Cohen Klingenstein sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 4,285 shares — an estimated $609K sold.
Cohen Klingenstein first reported a position in ZBH in Q2 2013 and held it in 34 quarters. The position peaked at $1.48M in Q2 2021. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.
- Cohen Klingenstein reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
- Cohen Klingenstein sold 4,285 Zimmer Biomet shares in Q4 2021, an estimated $609K.
- Cohen Klingenstein first reported a position in Zimmer Biomet in Q2 2013 and held it in 34 quarters.
- Cohen Klingenstein's Zimmer Biomet position peaked at $1.48M in Q2 2021.
- 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.
Based on Cohen Klingenstein's 13F filing for Q4 2021, filed 14 Jan 2022.